Breadcrumb Home Studies Studies Search Filter Research Area All Study Status AllClosed to AccrualClosed to Follow UpConcludedEnrollingIn DevelopmentParticipants Off Study and Primary Analysis CompletedPendingWithdrawn Sort Study Number AscStudy Number Desc Submit Search Showing 33 studies. P1093: PK, Safety, Tolerability and Antiviral Activity of Dolutegravir DAIDS Number 11773 Research Area Therapeutics Study Status Participants Off Study and Primary Analysis Completed P1089: Laboratory Study of Licensed H1N1 Influenza Vaccines in HIV-1 Perinatally Infected Chldren/youth DAIDS Number 11670 Research Area Other Study Status Concluded P1088: H1N1 INFLUENZA VACCINE IN HIV-INFECTED CHILDREN AND ADOLESCENTS DAIDS Number 10840 Research Area Other Study Status Concluded P1086: Phase II Study in HIV Positive Pregnant Women to Assess the Safety and Immunogen DAIDS Number 10835 Research Area Other Study Status Concluded P1081: 3 Regimens for HIV Infected Women initiating ARV regimens for PMTCT DAIDS Number 10770 Research Area Mother to child transmission Study Status Concluded 1077BF: PROMISE 1077BF DAIDS Number 10777 Research Area Prevention Study Status Participants Off Study and Primary Analysis Completed 1077HS: HAART Standard Version of the PROMISE Study (Maternal & Infant Survival) DAIDS Number 10779 Research Area Therapeutics Study Status Participants Off Study and Primary Analysis Completed 1077FF: PROMISE 1077FF DAIDS Number 10778 Research Area Therapeutics Study Status Participants Off Study and Primary Analysis Completed P1072: Safety and Immunogenicity of a Live, Attenuated, Rotavirus Vaccine (RotaTeq™) in HIV-1 Infected and Uninfected Children Born to HIV-1 Infected Mothers DAIDS Number 10638 Research Area Complications & Comorbidities Study Status Concluded P1071: CCR5 Vicriviroc (SCH-417690) DAIDS Number 10634 Research Area N/A Study Status Concluded Pagination Previous page Prev Page 1 Current page 2 Page 3 Page 4 Next page Next
P1093: PK, Safety, Tolerability and Antiviral Activity of Dolutegravir DAIDS Number 11773 Research Area Therapeutics Study Status Participants Off Study and Primary Analysis Completed
P1089: Laboratory Study of Licensed H1N1 Influenza Vaccines in HIV-1 Perinatally Infected Chldren/youth DAIDS Number 11670 Research Area Other Study Status Concluded
P1088: H1N1 INFLUENZA VACCINE IN HIV-INFECTED CHILDREN AND ADOLESCENTS DAIDS Number 10840 Research Area Other Study Status Concluded
P1086: Phase II Study in HIV Positive Pregnant Women to Assess the Safety and Immunogen DAIDS Number 10835 Research Area Other Study Status Concluded
P1081: 3 Regimens for HIV Infected Women initiating ARV regimens for PMTCT DAIDS Number 10770 Research Area Mother to child transmission Study Status Concluded
1077BF: PROMISE 1077BF DAIDS Number 10777 Research Area Prevention Study Status Participants Off Study and Primary Analysis Completed
1077HS: HAART Standard Version of the PROMISE Study (Maternal & Infant Survival) DAIDS Number 10779 Research Area Therapeutics Study Status Participants Off Study and Primary Analysis Completed
1077FF: PROMISE 1077FF DAIDS Number 10778 Research Area Therapeutics Study Status Participants Off Study and Primary Analysis Completed
P1072: Safety and Immunogenicity of a Live, Attenuated, Rotavirus Vaccine (RotaTeq™) in HIV-1 Infected and Uninfected Children Born to HIV-1 Infected Mothers DAIDS Number 10638 Research Area Complications & Comorbidities Study Status Concluded
